International Journal of Hematology and Oncology 2017, Vol 27, Num 3 Page(s): 195-201
A View from Young Oncologists on Clinical Trials in Turkey: Obstacles and Solution Proposals

Tulay AKMAN1, Ozgur TANRIVERDI2, Mehmet A. OZTURK3, Ibrahim PETEKKAYA4, Hakan BAKKAL5, Ozlem U. SONMEZ6, Nilufer AVCI7, Seyda ZENGIN8, Gorkem AKSU9, Gokhan OZYIGIT10, Huseyin ABALI11

1Tepecik Training and Research Hospital, Department of Medical Oncology, Izmir-TURKEY
2Sitki Kocman University Faculty of Medicine, Department of Medical Oncology, Mugla-TURKEY
3State Hospital, Department of Medical Oncology, Hatay-TURKEY
4Avukat Cengiz Gokcek Training and Research Hospital, Department of Medical Oncology, Gaziantep-TURKEY
5Bulent Ecevit University Faculty of Medicine, Department of Radiation Oncology, Zonguldak-TURKEY
6Yeditepe University Faculty of Medicine, Department of Medical Oncology, Istanbul-TURKEY
7State Hospital, Department of Medical Oncology, Balikesir-TURKEY
8Akdeniz University Faculty of Medicine, Department of Medical Oncology, Antalya-TURKEY
9Kocaeli University Faculty of Medicine, Department of Radiation Oncology, Kocaeli-TURKEY
10Hacettepe University Faculty of Medicine, Department of Radiation Oncology, Ankara-TURKEY
11Baskent University Faculty of Medicine, Department of Medical Oncology, Adana-TURKEY

Keywords: Oncology, Clinical trials, Turkey
There is a new improvement in oncology nearly in every day as a result of preclinical or clinical. As the number of publication per capita, Turkey is far behind the other developed European countries. For example, the number of publications in oncology field is 2.134.964 in the world, it is 15.576 in our country. The most important obstacles for clinical trials in Turkey may be listed as financial problems, difficulties of working conditions, time limitation due to work intensity, inadequate experienced/trained man-power, absence of assistance team at all steps of a scientific trial, difficulties faced during project planning and ethics committee submissions, and lack of motivation. In this article, we, as young oncologists, aimed to discuss the place of Turkey in areas of scientific and clinical trials in the world; underlying causes for inadequate number, type and quality of national studies and possible solution proposals in our country.